Publication of outcome should be welcomed, not feared

Retinal surgeons have nothing to lose and everything to gain from participating in the new retinal detachment database being launched by EURETINA and the British and Eire Association of Vitreoretinal Surgeons (BEAVRS), said BEAVRS president Bill Aylward FRCS, Moorfields Eye Hospital, London, UK .Speaking at the BEAVRS symposium held at this year’s EURETINA congress, Dr Aylward noted that many of the fears surgeons have are not only unfounded but also ignore the benefits that can be obtained through such databases Typical fears include the idea that surgeons who take on difficult cases and as a result have poorer results than those who only take on the easier cases will find themselves the object of opprobrium from health authorities, hospital management and even the press. As a result they will become reluctant to take on those difficult cases.
“The publication of data has hardly affected patient movement at all and hardly any surgeon has been hounded. And the very fact that an organisation collects and publishes data increases confidence,” he said. Furthermore, the results from cardiac surgeons in the UK suggest that reporting outcomes seems to improve outcomes. “The take-home message from the cardiac surgeon experience is that just by doing it. We don’t know why the standards go up and we don’t know why, but it’s a very interesting phenomenon,” Dr Aylward added.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.